We provide innovative gene editing reagents and screening services for the global R&D market. Our success is based on the proprietary 3Cs technology developed at Goethe University’s Institute of Biochemistry II (IBC2).
Vivlion is a spin-out of Goethe University founded in December 2018 by a team of scientists together with Goethe University as a shareholder. Seed funding was secured by a private equity company, gsccb Beteiligungsverwaltung GmbH.
Internationally renowned biomedical scientist and professor of Goethe University.
Lead inventor of 3Cs technology and group leader of Goethe University.
Experienced project manager with strong background in life sciences and journalism.
Vivlion is advised by representatives of Goethe University, Innovectis GmbH and gsccb Beteiligungsverwaltung GmbH.